Skip to main content

Médecine interne _ Internal medicine

The mission of the Institut Jules Bordet's Department of Internal Medicine is to assume responsibilitiy regarding:

  • Organising, with senior doctors from other specialities, the hospital's medical activity and support for undergraduate and postgraduate students 
  • Coordinating the various sister medical specialities of internal medicine, with the exception of those represented by departments concerned specifically with medical oncology and haematology. 
  • Intensive care
  • The oncological emergencies room
  • The infectious diseases clinic.
  • Providing training in internal medicine for medical students and doctors training to be a specialist  during the core years of internal medicine studies and higher training in internal medicine. 

Research projects

Project 1 (in progress)

L’inflammation a-t-elle une implication significative dans l’évolution du cancer bronchique ?

Project 2 (in progress)

COHESIS : Collaboration and Outreach in Hematological patients with/without Sepsis

Project 3 (in progress)

IMMUNO-REA : Caractéristiques et prise en charge des patients atteints d’une tumeur solide traités par immunothérapie admis en réanimation
  • Project initiator : Dr Anne-Pascale Meert
  • Financing: Intensive oncological care unit
  • Collaboration: GrrrOH

Project 4 (in progress)

Recommandations de pratique clinique pour le patient atteint d’une affection maligne admis en unité de soins intensifs.

Our team

Head of department
Prof. Anne-Pascale Meert
   (Caroline Gustin : Secretary)

Intensive care and oncological emergencies
Prof. Thierry Berghmans, head of clinic
Dr Bogdan Grigoriu, deputy head of clinic
Dr Vito Fontana, résident

Infectious diseases clinic
Prof. Michael Aoun, head of clinic
Dr Aspasia Georgala
Dr Angela Loizidou

Medical speciality
Dr Bogdan Grigoriu, pulmonology
Dr Nicolas Mavroudakis, neurology
Dr Lorenzo Ferlini, neurology
Dr François Delhaye, cardiology
Dr Nouar Elias, cardiology
Dr Costante, endocrinology
Dr Simenon, rhumatology

22/01/2020

 Scientific publications

Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the 'real-world' experience?

Authors : Costante G
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 3-8

Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium.

Authors : Koubaity M, Lechon AS, Amighi K, Van Nuffelen M, Moreau M, Meert AP, De Vriese C
Year : 2021
Journal : Support Care Cancer

[Perioperative treatment for resected non-small cell lung cancer: Which option in 2020?]

Authors : Coureau M, Berghmans T
Year : 2021
Journal : Rev Mal Respir

Risk factors for imminent fractures: a substudy of the FRISBEE cohort.

Authors : Iconaru L, Moreau M, Baleanu F, Kinnard V, Charles A, Mugisha A, Surquin M, Benoit F, Karmali R, Paesmans M, Body JJ, Bergmann P
Year : 2021
Journal : Osteoporos Int

Initiation of a new anti-cancer medical treatment in ICU: a retrospective study.

Authors : Chicoisneau M, Paesmans M, Ameye L, Sculier JP, Meert AP
Year : 2021
Journal : Acta Clin Belg
Pages : 1-9